2017
DOI: 10.3390/ijms18020402
|View full text |Cite
|
Sign up to set email alerts
|

An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach

Abstract: Sexually transmitted infections (STIs) are caused by a wide variety of bacteria, viruses, and parasites that are transmitted from one person to another primarily by vaginal, anal, or oral sexual contact. Syphilis is a serious disease caused by a sexually transmitted infection. Syphilis is caused by the bacterium Treponema pallidum subspecies pallidum. Treponema pallidum (T. pallidum) is a motile, gram-negative spirochete, which can be transmitted both sexually and from mother to child, and can invade virtually… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3
1

Relationship

2
7

Authors

Journals

citations
Cited by 45 publications
(34 citation statements)
references
References 49 publications
1
28
0
2
Order By: Relevance
“…The advances in immunoinformatics technology have changed the face of current medical research. Currently, this technology has widely been used for the evaluation of epitopes for constructing chimeric multi-epitope vaccine for various organisms including Hepatitis B Virus [40] or Escherichia coli [41], Dengue [42], Schistosoma haematobium [43], Treponema pallidum [44], Staphylococcus aureus [45] and Trypanosoma cruzi [46]. The feasibility and low cost enable the mapping of B-and T-cell epitopes of A-C pathogens that are available at the National Institute of Allergy and Infectious Diseases (NIAID) such as Bacillus anthracis (anthrax), Clostridium botulinum toxin (botulism), Variola major (small pox), rabies and influenza viruses.…”
Section: Future Prospect Of Immunoinformatics In Therapeutic Applicatmentioning
confidence: 99%
“…The advances in immunoinformatics technology have changed the face of current medical research. Currently, this technology has widely been used for the evaluation of epitopes for constructing chimeric multi-epitope vaccine for various organisms including Hepatitis B Virus [40] or Escherichia coli [41], Dengue [42], Schistosoma haematobium [43], Treponema pallidum [44], Staphylococcus aureus [45] and Trypanosoma cruzi [46]. The feasibility and low cost enable the mapping of B-and T-cell epitopes of A-C pathogens that are available at the National Institute of Allergy and Infectious Diseases (NIAID) such as Bacillus anthracis (anthrax), Clostridium botulinum toxin (botulism), Variola major (small pox), rabies and influenza viruses.…”
Section: Future Prospect Of Immunoinformatics In Therapeutic Applicatmentioning
confidence: 99%
“…For the prediction of vaccine targets, we used the subtractive genome approach adapted from Jaiswal et al [28]. Firstly, we used the core genome, that consists of the pathogen essential genes, and then we performed BLASTp analyses and predicted the non-host homologous targets.…”
Section: Reverse Vaccinology Approach For the Prediction Of Putativementioning
confidence: 99%
“…After applying GIPSy analysis and predicting three pathogenicity islands, we plotted the results in figure 2, using BRIG software [61]. Pathogenicity island prediction is very important for the knowledge about the virulence factors encoded and their mobility and structure, in understanding the bacterial evolution and the interactions between pathogen and eukaryotic host cells [28], thus these PAI host virulence factors that may be desirable vaccine candidates and elicit an immune response.…”
Section: Identification Of Intra-species Conserved Non-host Homologoumentioning
confidence: 99%
“…Syphilis has a worldwide distribution (e.g. Africa has a high incidence), affecting every country and continent except perhaps Antarctica [8][9][10][11][12]. The stages of syphilis have been divided on the basis of clinical findings that lead to treatment and follow-up.…”
Section: Introductionmentioning
confidence: 99%